IntelGenx Reports Third Quarter 2018 Financial Results
November 08, 2018 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
The Spanish Agency of Medicines and Medical Devices Grants Marketing Authorization of RIZAPORT®
October 31, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 31, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announced that its commercialization partner for...
IntelGenx Announces Successful Results from RIZAPORT® Bioequivalence Study
September 24, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Sept. 24, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced successful results from a bioequivalence study for...
IntelGenx Reports Second Quarter 2018 Financial Results
August 09, 2018 16:17 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 09, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the second quarter...
IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™
June 19, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a...
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
February 13, 2015 10:18 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...